Docetaxel

Results: 330



#Item
51In vivo isolation of circulating tumor cells in prostate cancer patients by a medical device G. Theil1, M.R. Hoda1, K. Fischer1, A. Schumann1, K. Haubold2, C. Boehm1, T. Krahn 3, N.G. Morgenthaler2, K. Luecke2, P. Fornar

In vivo isolation of circulating tumor cells in prostate cancer patients by a medical device G. Theil1, M.R. Hoda1, K. Fischer1, A. Schumann1, K. Haubold2, C. Boehm1, T. Krahn 3, N.G. Morgenthaler2, K. Luecke2, P. Fornar

Add to Reading List

Source URL: www.gilupi.de

Language: English - Date: 2014-05-27 05:35:07
52The team at Cerulean (NASDAQ: CERU) is committed to improving treatment for people living with cancer. We apply our Dynamic Tumor Targeting™ Platform to create a portfolio of nanoparticle-drug conjugates (NDCs) designe

The team at Cerulean (NASDAQ: CERU) is committed to improving treatment for people living with cancer. We apply our Dynamic Tumor Targeting™ Platform to create a portfolio of nanoparticle-drug conjugates (NDCs) designe

Add to Reading List

Source URL: www.ceruleanrx.com

Language: English - Date: 2015-06-01 11:12:23
53GUIDE TO THE PREVENTION OF  ll rig

GUIDE TO THE PREVENTION OF ll rig

Add to Reading List

Source URL: www.clinicaloncology.com

Language: English - Date: 2010-06-15 15:38:57
54Saladax Biomedical Names CEO Ahead of Series D, Diagnostic Test Launches VentureWire , Brian Gormley, June 15, 2012, (cDow Jones & Co. Inc.

Saladax Biomedical Names CEO Ahead of Series D, Diagnostic Test Launches VentureWire , Brian Gormley, June 15, 2012, (cDow Jones & Co. Inc.

Add to Reading List

Source URL: www.saladax.com

Language: English - Date: 2013-11-14 15:46:52
55Intranet “Internal News” Posting & Leading Edge article, authored by Kathy, Dede or Rob

Intranet “Internal News” Posting & Leading Edge article, authored by Kathy, Dede or Rob

Add to Reading List

Source URL: www.cmsastellas.ca

Language: English - Date: 2015-04-16 08:07:47
56Nitriles / Organofluorides / Benzoates / Carbamates / Abiraterone / MDV3100 / Prostate cancer / Docetaxel / Bicalutamide / Chemistry / Organic chemistry / Antiandrogens

5.5 ENZALUTAMIDE, capsule, 40 mg, Xtandi®, Astellas Pharma Australia Pty Ltd, Purpose of Application Authority required (Streamlined) listing for enzalutamide for treatment of metastatic prostate cancer after treatment

Add to Reading List

Source URL: www.pbs.gov.au

Language: English - Date: 2015-04-22 23:39:46
57

PDF Document

Add to Reading List

Source URL: www.pbs.gov.au

Language: English - Date: 2014-10-01 21:56:23
58Journal of Translational Medicine This Provisional PDF corresponds to the article as it appeared upon acceptance. Fully formatted PDF and full text (HTML) versions will be made available soon. Increased levels of choline

Journal of Translational Medicine This Provisional PDF corresponds to the article as it appeared upon acceptance. Fully formatted PDF and full text (HTML) versions will be made available soon. Increased levels of choline

Add to Reading List

Source URL: www.translational-medicine.com

Language: English
59landmarks  Assessing carboplatin and everolimus Victoria Mandilaras, MD, Resident; Nathaniel Bouganim, MD, Medical Oncologist; Jamil Asselah, MD, Medical Oncologist, McGill University Health Centre and Breast Disease Sit

landmarks Assessing carboplatin and everolimus Victoria Mandilaras, MD, Resident; Nathaniel Bouganim, MD, Medical Oncologist; Jamil Asselah, MD, Medical Oncologist, McGill University Health Centre and Breast Disease Sit

Add to Reading List

Source URL: www.oncologyex.com

Language: English - Date: 2015-03-04 15:16:24
60

PDF Document

Add to Reading List

Source URL: www.pbs.gov.au

Language: English - Date: 2015-04-22 23:39:46